This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets. The ceiling value of this award is $3,230.68, and the ultimate completion date is October 31, 2024. The contract is a firm-fixed-price instrument, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will be the prime contractor responsible for delivering this prescription medication to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 tablets of the prescription drug Envarsus XR 1 mg. The contract has a ceiling value of $2,432.22 and an ultimate completion date of September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Envarsus XR 0.75 mg tablets. The contract has a ceiling value of $2,128.84 and a period of performance ending on September 10, 2024. It is a Firm Fixed Price contract with no set-aside designation. The contract is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 mg tablets, a specialized medication. The total ceiling value of the contract is $1,711.95, with a performance period ending on April 17, 2025. This contract is not designated as a set-aside procurement. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Envarsus XR 1 mg tablets. The contract has a ceiling value of $1,216.11 and runs through September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product. The contract has a ceiling value of $1,288.86 and a performance period extending through May 28, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Envarsus XR 4 mg tablets. The contract has a ceiling value of $8,076.65 and an ultimate completion date of September 12, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, is leveraging its federal contracting experience and extensive supply chain to deliver this critical medication to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division for the supply of the pharmaceutical product Envarsus XR 1 mg tablet. The order has a firm fixed-price contract type and a ceiling value of $2,432.22. The order does not have a set-aside designation and has an ultimate completion date of September 9, 2024. Amerisourcebergen, one of the largest pharmaceutical distributors in the United States, has been awarded...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Envarsus XR 4 mg tablet, a medication used in transplant patients. The contract has a firm fixed price, with a ceiling value of $5,135.85, and a performance period through June 5, 2025. The contract is not set aside and is open to full and open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Envarsus XR 4 mg tablets in quantities of 100, with a ceiling value of $1,615.33 and a completion date of July 11, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation. Amerisourcebergen is a major pharmaceutical...